The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function

Artificial Organs

Volumn 33, Issue 8, 2009, Pages 641-647

  Garthwaite, Elizabeth ^a   Bhandari, Sunil ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitors; Hemodialysis; Hyperkalemia; Peritoneal dialysis; Potassium

Indexed keywords

BODY FLUIDS; HEMODIALYZERS; PATIENT TREATMENT; PHYSIOLOGY; POTASSIUM;

ANGIOTENSIN CONVERTING ENZYME INHIBITORS; DIALYSATES; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HYPERKALEMIA; PERITONEAL DIALYSIS; POTASSIUM HOMEOSTASIS; RENAL FUNCTIONS; TREATMENT GROUP;

DIALYSIS;

DIGOXIN; HEPARIN; LISINOPRIL; PERINDOPRIL; RAMIPRIL;

ARTICLE; DIALYSATE; DRUG EFFECT; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; POTASSIUM TRANSPORT; POTASSIUM URINE LEVEL; PRIORITY JOURNAL;

EID: 68549085161     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00790.x     Document Type: Article

References (16)

1. Bhandari S, Hunter M. Inward rectifier potassium channel (ROMK), the low-conductance channels for potassium secretion. Nephrol Dial Transplant 1998 13: 3019 23.
2. + and K+ transport of the cortical collecting duct. Am J Physiol 1985 248: F858.
3. Panese S, Virginillo M, Gimenez M, Litardo M, Arrizurieta E, Hayslett JP. Increased secretion of potassium in the rectum of humans with chronic renal failure. Am J Kidney Dis 1986 8: 105 10.
4. Agarwal R, Afzalpukar R, Fordtran JS. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology 1994 107: 548 71.
5. Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 2004 17: 196 201.
6. Knoll GA, Sahgal A, Nair RC, Graham J, van Walraven C, Burns KD. Renin-angiotensin system blockade and the risk of hyperkalaemia in chronic haemodialysis patients. Am. J Med 2002 112: 110 4.
7. Han SW, Woo YW, Yi JH, Kim HJ. No impact of hyperkalaemia with renin-angiotensin system blockages in maintenance haemodialysis patients. Nephrol Dial Transplant 2007 22: 1150 5.
8. Ahmed J, Weisberg LS. Hyperkalaemia in dialysis patients. Semin Dial 2001 14: 348 56.
9. Bakris GL, Siomos M, Richardson D, et al. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney Int 2000 58: 2084 92.
10. Hatch M, Freel RW, Varziri ND. Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure. Am J Physiol 1998 274: F275 82.
11. Mooser V, Fellay G, Regamey C. Hyperkalaemia during prolonged use of angiotensin II converting enzyme inhibitors in end-stage renal insufficiency. Schweiz Med Wochenschr 1992 122: 1927 9.
12. Phakdeekitchareon B, Leelasa-Nguan P. Effects of an ACE-inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis 2004 44: 738 46.
13. Atkin SL, Tomson CRV, Venning MC. Life threatening captopril induced hyperkalaemia in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1989 4: 1084.
14. Sandle GI, Butterfield I. Potassium secretion in rat distal colon during dietary potassium loading; role of pH regulated apical potassium channels. Gut 1999 44: 40 6.
15. Mathialahan T, Sandle G. Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease. Nephrol Dial Transplant 2003 18: 342 7.
16. Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in haemodialysis patients. Clin J Am Soc Nephrol 2007 2: 999 1007.